Novo Integrated Sciences (US:NVOS) — Company Overview, News & Financial Data
Novo Integrated Sciences delivers innovative healthcare therapies, integrating technology with multidisciplinary primary care.
Novo Integrated Sciences
Novo Integrated Sciences (NASDAQ:NVOS) is a company deeply invested in delivering innovative healthcare therapies and services. With a focus on multidisciplinary primary care, Novo is revolutionizing the way healthcare is delivered by integrating technology with medical and wellness specialties to provide accessible and holistic care solutions. The company operates through a mix of direct clinical services, digital health platforms, and technological advancements, aiming to bridge the gap between traditional medical care and advanced health innovations. Novo's projects include expanding its telemedicine services, developing new healthcare technologies, and increasing its market presence through strategic acquisitions. The objective is to create a seamless, patient-centered healthcare experience that is both efficient and effective, catering to the diverse needs of communities across various regions.
Snapshot
Operations
Products and/or services of Novo Integrated Sciences
- Multidisciplinary primary healthcare services, integrating medical and wellness care.
- Telemedicine and digital health platforms, connecting patients with healthcare providers.
- Advanced diagnostic assessments, including biomechanical and neurocognitive testing.
- Custom orthotics and prosthetics manufacturing, focusing on personalized patient care.
- Pharmaceutical solutions, emphasizing on prescribing and patient management.
- Educational support services for healthcare professionals, enhancing clinical proficiency.
Novo Integrated Sciences executive team
- Mr. Robert MattacchioneChairman of the Board & CEO
- Mr. Christopher Mehlin DavidCOO & Director
- Mr. Vivek Sethi C.A., CPAPrincipal Financial Officer & Principal Accounting Officer
- Dr. Joseph M. Chalil FACHE, M.B.A., M.D.Chief Medical Officer